Norovirus, a highly contagious stomach bug, is surging across the United States this winter, according to the latest data from the U.S. Centers for Disease Control and Prevention (CDC). The data shows 91 outbreaks of norovirus during the week of Dec. 5, a sharp rise from the 69 outbreaks recorded the previous week. For context, the first week of December has typically seen a maximum of 65 outbreaks in recent years. Often called the “stomach flu,” norovirus causes sudden vomiting, diarrhea, and other gastrointestinal symptoms. Outbreaks tend to occur in crowded settings such as nursing homes, schools, jails, and cruise ships. The report comes after a recent outbreak that infected over 300 individuals onboard three different cruise ships earlier this month. Norovirus spreads rapidly through direct contact with infected individuals or contaminated food, water, or surfaces. Sharing food, drinks, or utensils with someone infected can also transmit the virus. Symptoms usually appear 12 to 48 hours after exposure and last for one to three days. While most people recover fully, dehydration from vomiting and diarrhea can be dangerous, particularly for young children, older adults, and those with weakened immune systems. The best defense against norovirus is frequent and thorough handwashing with soap and warm water for at least 20 seconds, especially before meals. Disinfecting surfaces with household cleaners can also reduce the risk of infection.…  read on >  read on >

THURSDAY, Dec. 26, (2024 HealthDay News)  — The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for people living with Type 2 diabetes. Liraglutide, the generic for Victoza, is similar to semaglutide, the active ingredient in the popular weight-loss drug Ozempic. The FDA supports the development of generic drugs, such as GLP-1s, by funding research and informing industry through guidance, Dr. Iilun Murphy, director of the FDA’s Office of Generic Drugs, said. “Generic drugs provide additional treatment options which are generally more affordable for patients,” she said in a statement released Dec. 23, 2024. “Today’s approval underscores the FDA’s continued commitment to advancing patient access to safe, effective and high-quality generic drug products.” Last month, the agency approved the first generic version in this class of medications with the green lighting of a generic version of Byetta (exenatide). Experts hope the new approvals will help prevent shortages triggered by demand for injectable weight loss and type 2 diabetes drugs, including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). Liraglutide is expected to expand access for people managing type 2 diabetes, which affects more than 38 million Americans, according to federal health data. Type 2 diabetes is a chronic condition that occurs when the body does not use insulin well and cannot keep blood…  read on >  read on >

Virtual reality headsets like the Meta Quest or Apple Vision Pro will be a Christmas gift in more than one home this year. Now mice are getting in on the action. Researchers have developed a set of VR goggles for lab mice for use in brain studies, according to a report published recently in the journal Nature Methods. These VR goggles will allow scientists to provide immersive experiences for the mice, while capturing fluorescent images of the rodents’ brain activity. The goggles — which dwarf the tiny mice in size — were built using low-cost, off-the-shelf components like smartwatch displays and tiny lenses, researchers said. “It definitely benefited from the hacker ethos of taking parts that are built for something else and then applying it to some new context,” co-lead investigator Matthew Isaacson, a post-doctoral researcher at Cornell University, said in a news release from the college. “The perfect size display, as it turns out, for a mouse VR headset is pretty much already made for smart watches,” Isaacson continued. “We were lucky that we didn’t need to build or design anything from scratch. We could easily source all the inexpensive parts we needed.” Mice are frequently used in studies of brain activity. About a decade ago, researchers began rigging up clunky projector screens for mice as a means of creating virtual reality environments, but…  read on >  read on >

What type of “me-time” is more restorative to a person — hiking by yourself deep in a forest, or reading a book while sipping a latte in a coffee shop? Surprisingly, you’ll do best with a cup of joe and a good book, alone with yourself while surrounded by people, a new study published recently in the journal PLOS One found. Intense episodes of complete isolation aren’t as likely to benefit a person’s well-being as me-time that maintains some social connectedness. “We learned that less complete solitude is more likely to restore energy and maintain a feeling of connection with others,” lead researcher Morgan Quinn Ross, an assistant professor of communications with Oregon State University, said in a university news release. “In a world where social interaction is almost always just a click away, we need to understand how to balance social interaction with different types of solitude,” Ross added. For the study, researchers surveyed nearly 900 people regarding their mental health, preferred type of solitude and social interactions. The research team specifically assessed the conditions under which a person’s me-time might be intruded upon by people or technology, causing time alone to become more social in nature. Results show that less complete forms of solitude, like playing a game on your phone or going to a movie by yourself, offer some advantages over a…  read on >  read on >